Solid-state fermented brewer's spent grain enzymatic extract increases in vitro and in vivo feed digestibility in European seabass.

Brewer's spent grain (BSG) is the largest by-product originated from the brewery industry with a high potential for producing carbohydrases by solid-state fermentation. This work aimed to test the efficacy of a carbohydrases-rich extract produced from solid-state fermentation of BSG, to enhance the digestibility of a plant-based diet for European seabass (Dicentrarchus labrax). First, BSG was fermented with A. ibericus to obtain an aqueous lyophilized extract (SSF-BSG extract) and incorporated in a plant-based diet at increasing levels (0-control; 0.1%, 0.2%, and 0.4%). Another diet incorporating a commercial carbohydrases-complex (0.04%; Natugrain; BASF) was formulated. Then, all diets were tested in in vitro and in vivo digestibility assays. In vitro assays, simulating stomach and intestine digestion in European seabass, assessed dietary phosphorus, phytate phosphorus, carbohydrates, and protein hydrolysis, as well as interactive effects between fish enzymes and dietary SSF-BSG extract. After, an in vivo assay was carried out with European seabass juveniles fed selected diets (0-control; 0.1%, and 0.4%). In vitro digestibility assays showed that pentoses release increased 45% with 0.4% SSF-BSG extract and 25% with Natugrain supplemented diets, while amino acids release was not affected. A negative interaction between endogenous fish enzymes and SSF-BSG extract was observed in both diets. The in vivo digestibility assay corroborated in vitro data. Accordingly, the dietary supplementation with 0.4% SSF-BSG increased the digestibility of dry matter, starch, cellulose, glucans, and energy and did not affect protein digestibility. The present work showed the high potential of BSG to produce an added-value functional supplement with high carbohydrases activity and its potential contribution to the circular economy by improving the nutritional value of low-cost and sustainable ingredients that can be included in aquafeeds.

Aquaculture wastewater treatment through microalgal. Biomass potential applications on animal feed, agriculture, and energy.

The use of microalgae to remediate raw effluent from brown crab aquaculture was evaluated by performing batch mode growth tests using separately the microalgae Chlorella vulgaris (Cv), Scenedesmus obliquus (Sc), Isochrysis galbana (Ig), Nannocloropsis salina (Ns), and Spirulina major (Sp). Removal efficiencies in batch growth were 100% for total nitrogen and total phosphorus for all microalgae. Chemical oxygen demand (COD) remediations were all above 72%. Biomass productivity varied from 20.9 mg L-1 day-1 (N. salina) to 146.4 mg L-1 day-1 (C. vulgaris). The two best performing algae were C. vulgaris and S. obliquus and they were tested in semi-continuous growth, reaching productivities of 879.8 mg L-1 day-1 and 811.7 mg L-1 day-1, respectively. The bioremediation of the effluent was tested with a transfer system consisting of three independent containers and compared with the use of a single container. The single container had the same capacity and received weekly the same volume of effluent as the three containers together. The remediation capacity of the 3 containers was much higher than the single one. The supplementation with NaNO3 was tested to improve the nutrient removal microalgae' capacity, with positive results. The removal efficiencies were 100% for total nitrogen and total phosphorus and higher than 96% for COD. The obtained C. vulgaris and S. obliquus biomass were composed of 31 and 35% proteins, 6 and 8% lipids, 39 and 30% carbohydrates, respectively. The composition of these biomass suggest that it can be used as novel and sustainable ingredients in aquaculture feeds. The algal biomass of Cv and Sc were used as biostimulants in the germination of wheat and watercress, and very promising results were attained, with increases in the germination index for Cv and Sc of 175% and 48% in watercress and 84% and 98% in wheat, respectively. The biomasses of Cv and Sc were also subjected to a torrefaction process with 72.5 ± 1.7% char yields. The obtained biochars were tested as biostimulants for germination seeds (wheat and watercress) and as bio-adsorbent of dye solutions.

Reduction of inflammation and colon injury by a Pennyroyal phenolic extract in experimental inflammatory bowel disease in mice.

PURPOSE: Little is known about the pharmacological effects of the phenolic compounds of Pennyroyal (Mentha pulegium). This Mediterranean aromatic plant, used as a gastronomic spice and as food preservative by the food industry has been studied mainly due to its essential oil antibacterial properties, composed primarily by monoterpenes. With this work, we aimed to evaluate the effects of a phenolic extract of pennyroyal in the impairment of inflammatory processes in Inflammatory Bowel Diseases (IBD) and in the potential inhibition of progression to colorectal cancer (CRC). METHODS: To that purpose, we evaluated the effect of pennyroyal extract administration in a model of TNBS-induced colitis in mice and further determined its effect on human colon carcinoma cell proliferation and invasion. RESULTS: The phenolic extract of pennyroyal exhibited antioxidant properties in in vitro assays and administration of the extract in a rat model of carrageenan-induced paw oedema led to significant anti-inflammatory effects. Further results evidenced a beneficial effect of the phenolic extract in the attenuation of experimental colitis and a potential antiproliferative effect on cultured colon cancer cells, effects not previously described, to our knowledge. A reduction in several markers of colon inflammation was observed following administration of the extract to colitis-induced mice, including functional and histological indicators. A successful inhibition of cancer cell invasion and proliferation was also observed in in vitro studies with HT-29 cells. Furthermore, the extract also led to a reduced expression of iNOS/COX-2 in the colon of colitis-induced mice, both being crucial mediators of intestinal inflammation. CONCLUSIONS: Taking into consideration the central role of inflammation in the pathophysiology of CRC and the recognised connection between inflammatory events and cancer, these results enlighten the relevance of the phenolic constituents of pennyroyal as important pharmacological sources in the investigation of new treatment options for patients with inflammatory bowel diseases.